Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia

NCT00876304 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: PF-04802540
DRUG: Placebo

Sponsor

Taisho Pharmaceutical Co., Ltd.